HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bengt Erik Haug Selected Research

LTX-315

1/2017LTX-315: a first-in-class oncolytic peptide that reprograms the tumor microenvironment.
1/2017Oncolytic peptide LTX-315 induces an immune-mediated abscopal effect in a rat sarcoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bengt Erik Haug Research Topics

Disease

6Neoplasms (Cancer)
11/2019 - 01/2012
1Ovarian Neoplasms (Ovarian Cancer)
12/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Triple Negative Breast Neoplasms
11/2019
1Fibrosarcoma
01/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Acquired Immunodeficiency Syndrome (AIDS)
11/2015
1Legionnaires' Disease (Legionnaire's Disease)
11/2015
1Vasculitis (Vasculitides)
02/2014

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
01/2017 - 01/2012
3Pharmaceutical PreparationsIBA
11/2019 - 11/2015
2LTX-315IBA
01/2017 - 01/2017
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2021
1fluoromisonidazoleIBA
01/2021
1Antimicrobial Cationic PeptidesIBA
01/2017
1pyomelaninIBA
11/2015
1IronIBA
11/2015
1Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
11/2015
1EnzymesIBA
11/2015
1Serine Proteases (Serine Protease)IBA
02/2014
1AntigensIBA
02/2014
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
02/2014
1Myeloblastin (Proteinase 3)IBA
02/2014
1NitroreductasesIBA
02/2013

Therapy/Procedure

2Immunotherapy
01/2017 - 04/2016